Harrison, S. A., Neff, G., Guy, C. D., Bashir, M., Paredes, A., Pablo Fries, J., … Lieu, H. (2020). FINAL ANALYSIS OF A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ALDAFERMIN (NGM282) IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. In HEPATOLOGY (Vol. 72, pp. 55A-56A).

Harrison, Stephen A., Guy Neff, Cynthia D. Guy, Mustafa Bashir, Angelo Paredes, Juan Pablo Fries, Ziad H. Younes, et al. “FINAL ANALYSIS OF A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ALDAFERMIN (NGM282) IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS.” In HEPATOLOGY, 72:55A-56A, 2020.

Harrison SA, Neff G, Guy CD, Bashir M, Paredes A, Pablo Fries J, et al. FINAL ANALYSIS OF A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ALDAFERMIN (NGM282) IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. In: HEPATOLOGY. 2020. p. 55A-56A.

Harrison, Stephen A., et al. “FINAL ANALYSIS OF A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ALDAFERMIN (NGM282) IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS.” HEPATOLOGY, vol. 72, 2020, pp. 55A-56A.

Harrison SA, Neff G, Guy CD, Bashir M, Paredes A, Pablo Fries J, Younes ZH, Trotter JF, Gunn NT, Moussa S, Kohli A, Nelson K, Gottwald M, Chang W, Yan AZ, DePaoli A, Ling L, Lieu H. FINAL ANALYSIS OF A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ALDAFERMIN (NGM282) IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. HEPATOLOGY. 2020. p. 55A-56A.